
RTT News
<img alt="" height="1" width="1" />
Amgen Advances Effort To Sell Bone Drug For Cancer Patients
Wall Street Journal
NEW YORK (Dow Jones)--The third success of Amgen Inc.'s (AMGN) experimental bone drug denosumab in helping prevent bone complications in cancer patients increases the drug's chances of regulatory approval, ...
Amgen Sees Positive Data in Bone Drug StudyABC News
Positive Results on Amgen DrugZacks.com
Amgen: Denosumab demonstrates superiority over ZometaFierceBiotech
Benzinga -Reuters -Motley Fool
all 96 news articles »
More...